Skip to main content
Premium Trial:

Request an Annual Quote

Applera to Pay Genetic Technologies $11.2M as Part of Settlement

NEW YORK, Jan. 4 (GenomeWeb News) - A California court has formally dismissed the patent infringement suit between Genetic Technologies and Applera, GTG said today.

 

As reported by GenomeWeb News on Dec. 12, Applera agreed to settle the lawsuit over GTG's junk DNA gene-testing technologies on Dec. 9.

 

Under the settlement, Applera agreed to take a license to the GTG non-coding patents and will make payments in the form of cash, equipment, reagents and intellectual property. The payments will total approximately AU$15 million ($11.2 million), GTG said.

 

The Northern California District Court formally dismissed the lawsuit on Dec. 30.

 

GTG has favourably resolved six lawsuits involving its patents and does not have any other cases pending.

The Scan

Not Immediately Told

The US National Institutes of Health tells lawmakers that one of its grantees did not immediately report that it had developed a more infectious coronavirus, Science says.

Seems Effective in Kids

The Associated Press reports that the Pfizer-BioNTech SARS-CoV-2 vaccine for children appears to be highly effective at preventing symptomatic disease.

Intelligence Warning on Bioeconomy Threats

US intelligence warns over China's focus on technologies and data related to the bioeconomy, the New York Times reports.

PLOS Papers on Campylobacteriosis Sources, Inherited Retinal Dystrophies, Liver Cancer Prognosis

In PLOS this week: approach to uncover source of Campylobacteriosis, genetic risk factors for inherited retinal dystrophies, and more.